The acceptability of self-administration of subcutaneous Depo-Provera

Contraception

Volumn 72, Issue 1, 2005, Pages 14-18

  Lakha, Fatim ^a,b   Henderson, Charlotte ^a   Glasier, Anna ^a,b  

^a NHS LOTHIAN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Acceptability; Contraception; Depo Provera; Self administration; Subcutaneous

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ARTICLE; CONTRACEPTION; DRUG SELF ADMINISTRATION; FEAR; FEMALE; HEALTH SURVEY; HUMAN; NEEDLE; QUESTIONNAIRE;

CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MEDROXYPROGESTERONE 17-ACETATE; PATIENT SATISFACTION; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 20444471191     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.12.002     Document Type: Article

References (8)

1. Population Reports. New era for injectables. 1995, volume XXIII, number 2. Series K, No 5.
2. Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States: 1982-1995. Fam Plann Perspect 1998;30:4-10, 46.
3. F. Dawe H. Meltzer Contraception and sexual health 2002 Office for National Statistics London Available at: www.statistics.gov.uk
4. World Health Organization Selected practice recommendations for contraceptive use 2002 WHO Geneva Available at: www.who.int/reproductive-health/ publications/rhr_02_7
5. J. Jain, C. Dutton, A. Nicosia, C. Wajszczuk, F.R. Bode, and D.R. Mishell Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo Provera Contraception 70 2004 11 18
6. S.K. Henshaw Unintended pregnancy in the United States Fam. Plann. Perspect. 30 1998 24 29
7. L. Bahamondes, N.M. Marchi, and H.M. Nakagava Self-administration with Uniject® of the once-a-month injectable contraceptive Cyclofem Contraception 56 1997 301 304
8. L.M. Keder, M.C. Rulin, and J. Gruss Compliance with depot medroxyprogesterone acetate: a randomized controlled trial of intensive reminders Am. J. Obstet. Gynecol. 169 1995 583 585